Skip to content

Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States

Iodinated Contrast Agents and Risk of Hypothyroidism in Young Children in the United States

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02959827
Enrollment
2320
Registered
2016-11-09
Start date
2016-10-15
Completion date
2017-06-15
Last updated
2019-01-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypothyroidism

Keywords

Hypothyroidism,, children,, iodinated contrast agents,, retrospective cohort,, database

Brief summary

This study will estimate the incidence of hypothyroidism in a pediatric population of children under age 4, based on data from the US-based Kaiser Permanente Northern California database, which were exposed to iodinated contrast agent through having a diagnostic procedure.

Interventions

Use of iodine contrast agents and doses following the decision of the treating physician.

Sponsors

Bayer
Lead SponsorINDUSTRY

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 3 Years
Healthy volunteers
No

Inclusion criteria

* Children under age 4 in the Kaiser Permanente Northern California (KPNC) database, who had a diagnostic procedure with an iodinated contrast agent. * Participants should be member of the KPNC for at least 3 months before the iodinated contrast exposure, except where the child is under 3 months of age at time of initial exposure, and 2 weeks after the exposure.

Exclusion criteria

* Diagnosis of hypothyroid any time prior to the iodine contrast exposure. * Lab values for low thyroid (TSH \> 5 mU/L for children) any time before the exposure * Thyroid replacement therapy, Hashimoto thyroiditis, or congenital hypothyroidism any time prior to exposure.

Design outcomes

Primary

MeasureTime frameDescription
Incidence Rate of Hypothyroidism Detected in Routine Clinical PracticeIn the 365 days post exposure to an iodinated contrast agentIncidence density rates (IDR) were calculated as the number of cases over the person time at risk where the numerator was the number of cases and the denominator was the person years at risk.

Secondary

MeasureTime frame
Baseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortUp to 365 days after a diagnostic scan with iodinated contrast agent
Baseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the CohortUp to 365 days after a diagnostic scan with iodinated contrast agent
Baseline Characteristics (Type of Iodine Contrast Exposure) of the Cases With Hypothyroidism and of the Rest of the CohortUp to 365 days after a diagnostic scan with iodinated contrast agent
Baseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the CohortUp to 365 days after a diagnostic scan with iodinated contrast agent
Time From First Iodinated Contrast to First Hypothyroidism EventUp to 365 days after a diagnostic scan with iodinated contrast agent
Classification of Subclinical/Manifest Hypothyroidism by Type of ExposureUp to 365 days after a diagnostic scan with iodinated contrast agent
Classification of Hypothyroidism by EtiologyUp to 365 days after a diagnostic scan with iodinated contrast agent
Baseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortUp to 365 days after a diagnostic scan with iodinated contrast agent

Countries

United States

Participant flow

Recruitment details

This study was a retrospective cohort study, using the data from the years 2008 to June of 2016 in the database of Kaiser Permanente Northern California.

Pre-assignment details

There were 2320 children identified in Kaiser Permanente Northern California who met our study population criteria: patients who had a procedure that used iodinated contrast agent and were under the age of 4, during the years 2008 to June of 2016.

Participants by arm

ArmCount
Iodine Contrast Agent
Children under age 4, from the US-based Kaiser Permanente Northern California database, who were exposed to iodinated contrast agent through having a diagnostic procedure.
2,320
Total2,320

Baseline characteristics

CharacteristicIodine Contrast Agent
Age, Customized
<1 month
197 Participants
Age, Customized
1 to 3 months
174 Participants
Age, Customized
1 to 4 years
1518 Participants
Age, Customized
3 to 6 months
174 Participants
Age, Customized
6 months to 1 year
257 Participants
Race/Ethnicity, Customized
African American
174 Participants
Race/Ethnicity, Customized
Asian/Pacific islander
425 Participants
Race/Ethnicity, Customized
Hispanic
726 Participants
Race/Ethnicity, Customized
Other or missing
195 Participants
Race/Ethnicity, Customized
White
800 Participants
Sex: Female, Male
Female
1032 Participants
Sex: Female, Male
Male
1288 Participants

Adverse events

Event typeEG000
affected / at risk
deaths
Total, all-cause mortality
0 / 0
other
Total, other adverse events
0 / 0
serious
Total, serious adverse events
0 / 0

Outcome results

Primary

Incidence Rate of Hypothyroidism Detected in Routine Clinical Practice

Incidence density rates (IDR) were calculated as the number of cases over the person time at risk where the numerator was the number of cases and the denominator was the person years at risk.

Time frame: In the 365 days post exposure to an iodinated contrast agent

ArmMeasureValue (MEAN)
Iodine Contrast AgentIncidence Rate of Hypothyroidism Detected in Routine Clinical Practice15.9 events per 1,000 person years
Secondary

Baseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort

Time frame: Up to 365 days after a diagnostic scan with iodinated contrast agent

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort1 to 3 months6 Participants
Iodine Contrast AgentBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort3 to 6 months6 Participants
Iodine Contrast AgentBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort6 months to 1 year4 Participants
Iodine Contrast AgentBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort1 to 4 years14 Participants
Iodine Contrast AgentBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort<1 month4 Participants
Non-hypothyroidism CasesBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort<1 month193 Participants
Non-hypothyroidism CasesBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort1 to 4 years1504 Participants
Non-hypothyroidism CasesBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort3 to 6 months168 Participants
Non-hypothyroidism CasesBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort1 to 3 months168 Participants
Non-hypothyroidism CasesBaseline Characteristics (Age) of the Cases With Hypothyroidism and of the Rest of the Cohort6 months to 1 year253 Participants
Secondary

Baseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the Cohort

Time frame: Up to 365 days after a diagnostic scan with iodinated contrast agent

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortWhite13 Participants
Iodine Contrast AgentBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortHispanic6 Participants
Iodine Contrast AgentBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortAfrican American4 Participants
Iodine Contrast AgentBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortAsian/Pacific islander9 Participants
Iodine Contrast AgentBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortOther or missing2 Participants
Non-hypothyroidism CasesBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortAsian/Pacific islander416 Participants
Non-hypothyroidism CasesBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortOther or missing193 Participants
Non-hypothyroidism CasesBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortWhite787 Participants
Non-hypothyroidism CasesBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortAfrican American170 Participants
Non-hypothyroidism CasesBaseline Characteristics (Race/Ethnicity) of the Cases With Hypothyroidism and of the Rest of the CohortHispanic720 Participants
Secondary

Baseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the Cohort

Time frame: Up to 365 days after a diagnostic scan with iodinated contrast agent

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentBaseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortMale24 Participants
Iodine Contrast AgentBaseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortFemale10 Participants
Non-hypothyroidism CasesBaseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortMale1264 Participants
Non-hypothyroidism CasesBaseline Characteristics (Sex) of the Cases With Hypothyroidism and of the Rest of the CohortFemale1022 Participants
Secondary

Baseline Characteristics (Type of Iodine Contrast Exposure) of the Cases With Hypothyroidism and of the Rest of the Cohort

Time frame: Up to 365 days after a diagnostic scan with iodinated contrast agent

ArmMeasureCategoryValue (COUNT_OF_UNITS)
Iodine Contrast AgentBaseline Characteristics (Type of Iodine Contrast Exposure) of the Cases With Hypothyroidism and of the Rest of the CohortCT scan18 Iodine contrast exposure
Iodine Contrast AgentBaseline Characteristics (Type of Iodine Contrast Exposure) of the Cases With Hypothyroidism and of the Rest of the CohortHeart catheterization16 Iodine contrast exposure
Non-hypothyroidism CasesBaseline Characteristics (Type of Iodine Contrast Exposure) of the Cases With Hypothyroidism and of the Rest of the CohortCT scan1762 Iodine contrast exposure
Non-hypothyroidism CasesBaseline Characteristics (Type of Iodine Contrast Exposure) of the Cases With Hypothyroidism and of the Rest of the CohortHeart catheterization528 Iodine contrast exposure
Secondary

Baseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort

Time frame: Up to 365 days after a diagnostic scan with iodinated contrast agent

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort20156 Participants
Iodine Contrast AgentBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohortthrough August 20160 Participants
Iodine Contrast AgentBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort20084 Participants
Iodine Contrast AgentBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort20093 Participants
Iodine Contrast AgentBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort20109 Participants
Iodine Contrast AgentBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort20112 Participants
Iodine Contrast AgentBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort20122 Participants
Iodine Contrast AgentBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort20134 Participants
Iodine Contrast AgentBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort20144 Participants
Non-hypothyroidism CasesBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort2013263 Participants
Non-hypothyroidism CasesBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort2015241 Participants
Non-hypothyroidism CasesBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort2011260 Participants
Non-hypothyroidism CasesBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohortthrough August 2016105 Participants
Non-hypothyroidism CasesBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort2008300 Participants
Non-hypothyroidism CasesBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort2012266 Participants
Non-hypothyroidism CasesBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort2009320 Participants
Non-hypothyroidism CasesBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort2014234 Participants
Non-hypothyroidism CasesBaseline Characteristics (Year of Hypothyroidism Diagnosis) of the Cases With Hypothyroidism and of the Rest of the Cohort2010297 Participants
Secondary

Classification of Hypothyroidism by Etiology

Time frame: Up to 365 days after a diagnostic scan with iodinated contrast agent

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentClassification of Hypothyroidism by EtiologyIodine induced cases23 Participants
Iodine Contrast AgentClassification of Hypothyroidism by EtiologyOther etiology cases11 Participants
Secondary

Classification of Subclinical/Manifest Hypothyroidism by Type of Exposure

Time frame: Up to 365 days after a diagnostic scan with iodinated contrast agent

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentClassification of Subclinical/Manifest Hypothyroidism by Type of ExposureSubclinical hypothyroidism15 Participants
Iodine Contrast AgentClassification of Subclinical/Manifest Hypothyroidism by Type of ExposureManifest hypothyroidism2 Participants
Iodine Contrast AgentClassification of Subclinical/Manifest Hypothyroidism by Type of ExposureTreatment or diagnosis with no TSH test1 Participants
Non-hypothyroidism CasesClassification of Subclinical/Manifest Hypothyroidism by Type of ExposureSubclinical hypothyroidism9 Participants
Non-hypothyroidism CasesClassification of Subclinical/Manifest Hypothyroidism by Type of ExposureManifest hypothyroidism1 Participants
Non-hypothyroidism CasesClassification of Subclinical/Manifest Hypothyroidism by Type of ExposureTreatment or diagnosis with no TSH test6 Participants
Secondary

Time From First Iodinated Contrast to First Hypothyroidism Event

Time frame: Up to 365 days after a diagnostic scan with iodinated contrast agent

ArmMeasureCategoryValue (COUNT_OF_PARTICIPANTS)
Iodine Contrast AgentTime From First Iodinated Contrast to First Hypothyroidism Event<30 days4 Participants
Iodine Contrast AgentTime From First Iodinated Contrast to First Hypothyroidism Event30 - 59 days4 Participants
Iodine Contrast AgentTime From First Iodinated Contrast to First Hypothyroidism Event60+ days10 Participants
Non-hypothyroidism CasesTime From First Iodinated Contrast to First Hypothyroidism Event<30 days3 Participants
Non-hypothyroidism CasesTime From First Iodinated Contrast to First Hypothyroidism Event30 - 59 days3 Participants
Non-hypothyroidism CasesTime From First Iodinated Contrast to First Hypothyroidism Event60+ days10 Participants

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026